Lupin Ltd. Sees Revision in Score Amid Strong Market Performance Lupin Ltd., a leading name in the Pharmaceuticals & Drugs sector, has recently garnered attention as its stock price reached a new 52-week high of Rs. 2328.4 on December 30, 2024. This achievement is indicative of the company's strong performance, as it outperformed its sector by 2.55% on the same day. In the past week, Lupin has shown impressive upward momentum, with a notable increase in returns of 7.79%. The stock's resilience is further emphasized by its trading position, consistently remaining above key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. In light of these developments, MarketsMOJO has made an adjustment in its evaluation of Lupin, resulting in a revision in its score. This change highlights the company's robust performance metrics and solid market position. As a large-cap entity, Lupin continues to strengthen its standing within the industry, boasting an impressive one-year performance of 74.94%, significantly surpassing the Sensex, which recorded an 8.32% increase during the same timeframe. Moreover, Lupin has been added to MarketsMOJO's list, reflecting its strong fundamentals and favorable market dynamics.

Dec 30 2024 03:35 PM IST
share
Share Via
Lupin Ltd. has recently experienced a revision in its stock evaluation, reflecting its strong market performance. The stock reached a 52-week high, outperforming its sector and demonstrating consistent gains over the past five days. Additionally, Lupin has been added to MarketsMojo's list, highlighting its robust returns compared to broader market indices.
Lupin Ltd. Sees Revision in Score Amid Strong Market Performance

Lupin Ltd., a leading name in the Pharmaceuticals & Drugs sector, has recently garnered attention as its stock price reached a new 52-week high of Rs. 2328.4 on December 30, 2024. This achievement is indicative of the company's strong performance, as it outperformed its sector by 2.55% on the same day.

In the past week, Lupin has shown impressive upward momentum, with a notable increase in returns of 7.79%. The stock's resilience is further emphasized by its trading position, consistently remaining above key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages.

In light of these developments, MarketsMOJO has made an adjustment in its evaluation of Lupin, resulting in a revision in its score. This change highlights the company's robust performance metrics and solid market position. As a large-cap entity, Lupin continues to strengthen its standing within the industry, boasting an impressive one-year performance of 74.94%, significantly surpassing the Sensex, which recorded an 8.32% increase during the same timeframe.

Moreover, Lupin has been added to MarketsMOJO's list, reflecting its strong fundamentals and favorable market dynamics.
Lupin Ltd., a prominent player in the Pharmaceuticals & Drugs sector, has recently made headlines as its stock price reached a new 52-week high of Rs. 2328.4 on December 30, 2024. This milestone reflects a strong performance, with the stock outperforming its sector by 2.55% on the same day.
Over the past five days, Lupin has demonstrated consistent upward momentum, achieving a notable 7.79% increase in returns. The stock's resilience is further highlighted by its trading position, as it remains above key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. In light of these developments, MarketsMOJO has made an adjustment in its evaluation of Lupin, indicating a revision in its score. This change underscores the company's robust performance metrics and market position. As a large-cap entity, Lupin continues to solidify its standing within the industry, showcasing a remarkable one-year performance of 74.94%, significantly outpacing the Sensex, which recorded an 8.32% increase during the same period. Additionally, Lupin has been added to MarketsMOJO's list, reflecting its strong fundamentals and market dynamics.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News